Morning Ireland podcast

Immunising infants and older people against RSV found to not be cost-effective - HIQA

28/04/2026
0:00
2:54
Recuar 15 segundos
Avançar 15 segundos
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.

See omnystudio.com/listener for privacy information.

Mais episódios de "Morning Ireland"